• Cy5 TSA Fluorescence System Kit for Astrocytes

  2026-09-20

  Map subtle astrocyte differences across brain regions and developmental stages with rapid HRP-driven Cy5 deposition. This workflow guide shows how to adapt atlas-informed ICC, IHC, and FISH experiments for detection of low-abundance targets while controlling background and preserving spatial resolution.

• Mutant p53-R280K Drives Breast Cancer Lipogenesis

  2026-09-19

  The reference study identifies a gain-of-function mechanism in which mutant p53-R280K co-opts SREBP1 to activate FASN transcription, increasing de novo fatty acid synthesis and promoting breast cancer progression. Genetic and pharmacological FASN inhibition links this metabolic pathway to proliferation, invasion, tumor growth, and lung metastasis, while also defining a mutation-specific therapeutic vulnerability.

• Biotin-tyramide: Practical TSA Workflow Guide

  2026-09-19

  Biotin-tyramide is a biotinylation reagent for HRP-dependent tyramide signal amplification in fixed-cell and tissue assays, including immunohistochemistry and in situ hybridization. It should be used for research workflows requiring localized biotin deposition and downstream streptavidin detection, not for diagnostic, therapeutic, or medical applications.

• Rucaparib for DNA Damage Response Research

  2026-09-18

  Rucaparib (AG-014699) helps researchers connect PARP1 blockade with persistent DNA lesions, radiosensitization, and cell-death signaling in repair-deficient models. This workflow-focused guide shows how to control formulation, treatment timing, transporter effects, and orthogonal readouts for more interpretable cancer biology experiments.

• Epalrestat: From Polyol Control to Neuroprotection

  2026-09-17

  Epalrestat is more than a conventional aldose reductase inhibitor: emerging evidence connects polyol pathway inhibition with KEAP1/Nrf2-driven antioxidant defense, mitochondrial protection, and dopaminergic neuron survival. This article translates that mechanistic convergence into practical guidance for diabetic neuropathy research, oxidative stress research, and Parkinson’s disease models.

• BQCA and M1 Signaling: From Potency to Bias

  2026-09-17

  Benzyl Quinolone Carboxylic Acid (BQCA) is more than an M1 receptor potentiator: it is a tool for separating receptor potency, pathway efficacy, and signaling bias. This article translates recent GRK–M1 interaction findings into practical assay and Alzheimer’s disease research decisions.

• OLIG2 mRNA Drives Rapid hiPSC Oligodendrocyte Differentiatio

  2026-09-17

  Xu and colleagues developed a transgene-free strategy for differentiating human induced pluripotent stem cells into oligodendrocyte progenitor cells using modified messenger RNA encoding OLIG2S147A. Repeated delivery produced stable factor expression, generated NG2-positive progenitors in a six-day protocol, and yielded cells capable of maturation and remyelination-related activity in vitro and in vivo.

• Gemcitabine Workflows for DNA Damage Assays

  2026-09-16

  Build reproducible Gemcitabine experiments that connect replication stress with checkpoint signaling, apoptosis, and chemotherapy sensitivity. This workflow translates pancreatic cancer findings involving GPX3 and JNK/c-Jun into practical assay design while remaining useful for osteosarcoma and broader cancer research.

• Engineering mRNA Workflows for Disc Repair

  2026-09-15

  The emerging strategy of LNP-mRNA-engineered fibroblasts reframes mRNA synthesis as a translational design variable. This article connects inflammatory biology, transcript production, cell engineering, and preclinical decision-making for researchers developing localized regenerative therapies.

• SpCas9 mRNA: Designing Transient CRISPR Editing

  2026-09-15

  SpCas9 mRNA enables transient CRISPR-Cas9 genome editing without introducing a DNA expression cassette. This guide connects mRNA chemistry, embryo delivery, repair biology, and assay design to help researchers plan more interpretable genome engineering experiments.

• Protease Inhibitor Cocktail for Plant Assays

  2026-09-14

  Protect plant proteins from extraction through Western blotting, co-immunoprecipitation, pull-down, and kinase workflows with an EDTA-free, broad-spectrum formulation. This practical guide connects plant protein preservation with SHP2 mutation research while clearly separating validated product use from cross-domain experimental hypotheses.

• Nitrocefin: Practical β-Lactamase Assay Workflows

  2026-09-14

  Nitrocefin converts β-lactamase activity into a rapid yellow-to-red signal for resistance profiling, enzyme characterization, and inhibitor screening. This guide connects practical assay setup with a peptide-discovery workflow reported for TEM-1 β-lactamase, including controls, optimization strategies, and troubleshooting.

• Anti-ROR1 Antibody (Zilovertamab) Guide

  2026-09-13

  Anti-ROR1 Antibody (Zilovertamab) is a humanized IgG1 reagent designed to bind ROR1 and inhibit Wnt5a-induced ROR1 signaling. The F1460 product supports ELISA, FACS, kinetic, functional, and animal-model workflows, but its product-level binding data do not establish clinical efficacy or activity in deoxynivalenol-induced liver injury.

• Concanavalin A Targets Conserved Coronavirus Glycans

  2026-09-12

  This study identifies phylogenetically conserved N-linked glycans near the coronavirus spike S2′ cleavage site as a broad-spectrum antiviral vulnerability. Using fusion, pseudovirus, authentic infection, biochemical, and animal models, the authors show that concanavalin A blocks spike activation and reduces hCoV-NL63 disease-related outcomes in mice.

• Targeting Fructose Metabolism in Cancer Therapy

  2026-09-12

  This 2025 Cancer Letters review integrates fructose transport, the polyol pathway, tumor bioenergetics, mTORC1 signaling, and immune regulation into a unified framework for cancer therapy. Its main practical implication is that fructose metabolism may offer both biomarker opportunities and combination-treatment targets, although the evidence remains primarily mechanistic and preclinical.

8478 records 1/566 page Next 12345 下5页 Last page